Nitroimidazoles. V. Synthesis and anti-HIV evaluation of new 5-substituted piperazinyl-4-nitroimidazole derivatives

T. L. Loo, J. K. Luce, J. H. Jardine and E. Frei, Pharmacologic studies of the anti-tumor agent 5-(dimethyltriazeno)imidazole-4-carboxamide, Cancer Res.28 (1968) 2448-2453.Search in Google Scholar

J. E. Biskupiak, J. R. Grierson, J. S. Rasey, G. V. Martin and K. A. Krohn, Synthesis of an (iodovinyl) misonidazole derivative for hypoxia imaging, J. Med. Chem.34 (1991) 2165-2168; DOI: 10.1021/jm00111a036.10.1021/jm00111a0362066990Search in Google Scholar

J. Bartroli, M. Alguero, Boncompte and J. Forn, Synthesis and antifungal activity of a series of difluorotritylimidazoles, Arzneim.-Forsch.42 (1992) 832-835.Search in Google Scholar

I. Saji, K. Tamoto, H. Yamazaki and H. Agui, A novel thermal rearrangement of 1-tritylimidazoles, Heterocycles15 (1981) 943-945; DOI: S-1981-02-0943.10.3987/S-1981-02-0943Search in Google Scholar

W. J. Ross, W. B. Jamieson and M. C. McCowen, Antiparasitic nitroimidazoles. 3. Synthesis of 2-(4-carboxystyryl)-5-nitro-1-vinylimidazole and related compounds, J. Med. Chem.16 (1973) 347-352; DOI: 10.1021/jm00262a008.10.1021/jm00262a0084351912Search in Google Scholar

T. Fujiwara, A. Sato, M. El-Farrash, S. Miki, K. Kabe, Y. Isaka, M. Kodama, Y. M. Wu, L. B. Chen, H. Harada, H., Sugimoto, M. Hatanaka and Y. Hinuma, S-1153 Inhibits replication of known drug-resistant strains of human immunodeficiency virus type 1, Antimicrob. Agents Chemother.42 (1998) 1340-1345; DOI: 0066-4804/98.10.1128/AAC.42.6.13401056009624472Search in Google Scholar

J. C. Erik, H. Van der Goot, G. J. Sterk and H. Timmerman, Histamine H₂-receptor agonists. Synthesis, in vitro pharmacology, and qualitative structure-activity relationships of substituted 4-and 5-(2-aminoethyl)thiazoles, J. Med. Chem.35 (1992) 3239-3246; DOI:10.1021/jm00095a021.10.1021/jm00095a0211507209Search in Google Scholar

J. T. Kovalainen, J. A. M. Christiaans, S. Kotisaari, J. T. Laitinen, P. T. Männistö, L. Tuomisto and J. Gynther, Synthesis and in vitro pharmacology of a series of new chiral histamine H₃-receptor ligands: 2-(R and S)-amino-3-(1H-imidazol-4(5)-yl)propyl ether derivatives, J. Med. Chem.42 (1999) 1193-1202; DOI: 10.1021/jm980408v.10.1021/jm980408v10197963Search in Google Scholar

S. C. Farsch, J. A. Nick, V. A. Fadok, D. L. Bratton, G. S. Worthen and P. M. Henson, p38 Mitogen-activated protein kinase-dependent and -independent intracellular signal transduction pathways leading to apoptosis in human neutrophils, J. Biol. Chem.273 (1998) 8389-8397.10.1074/jbc.273.14.83899525949Search in Google Scholar

L. Salerno, V. Sorrenti, F. Guerrera, M. C. Sarva, M. A. Siracusa, C. Di Giacomo and A. Vanella, N-substituted-imidazoles as inhibitors of nitric oxide synthase: a preliminary screening, Pharmazie54 (1999) 685-690.Search in Google Scholar

M. Castelli, M. Malagoli, L. Lupo, S. Roffia, F. Paolucci, C. Cermelli, A. Zanca and G. Baggio, Cytotoxicity and probable mechanism of action of sulphimidazole, J. Antimicrob. Chemother.46 (2000) 541-550; DOI:10.1093/jac/46.4.541.10.1093/jac/46.4.54111020250Search in Google Scholar

G. E. Adams, E. D. Clarke, I. R. Flockhart, R. S. Jacobs, D. S. Sehmi, I. J. Stratford, P. Wardman, M. E. Watts, J. Parrick, R. G. Wallace and C. E. Smithen, Structure-activity relationships in the development of hypoxic cell radiosensitizers I. Sensitization efficiency, Int. J. Radiat. Biol.35 (1979) 133-150; DOI: 10.1080/09553007914550161.10.1080/09553007914550161312784Search in Google Scholar

P. Noker, L. Simpson-Herren and S. D. Wagoner, Distribution of nitroimidazoles and L-phenylalanine mustard in mammary adenocarcinoma 16/C tumors, Cancer Chemother. Pharm.20 (1987) 188-192; DOI: 10.1007/BF00570482.10.1007/BF005704823677296Search in Google Scholar

S. Kulkarni, M. R. Grimmett, L. R. Hanton and J. Simpson, Nucleophilic displacements of imidazoles. I. Oxygen, nitrogen and carbon nucleophiles, Aust. J. Chem.40 (1987) 1399-1413; DOI: 10.1071/CH9871399.10.1071/CH9871399Search in Google Scholar

S. Sobiak, Synthesis of some 5-amino-2-methyl-4-nitro-1-phenacylimidazoles, Pol. J. Chem.72 (1998) 78-83.Search in Google Scholar

L. Zaprutko, M. Gajdzinski, W. Michalska, K. Pitkiewicz, K. Lutomski, Z. Lukaszewski and U. Wrzeciono, Azole. 44.1 Über Morpholinonitroimidazolderivate, Pharmazie44 (1989) 817-820.Search in Google Scholar

Y. A. Al-Soud and N. A. Al-Masoudi, An unexpected reactivity during the cyclization of 3-(5-amino-3-benzyl-2-ethyl-3H-imidazole-4-ylsulfanyl)propionic acid methyl ester, Synth. Commun.35 (2005) 2258-2264; DOI: 10.1080/00397910500184735.10.1080/00397910500184735Search in Google Scholar

N. A. Al-Masoudi, Y. A. Al-Soud, A. Kalogerakis, E. De Clercq and C. Pannecouque, Nitroimidazoles. Part 2. Synthesis, antiviral and antitumor activity of new 4-nitroimidazoles, Chem. Biodiver.3 (2006) 515-526; DOI: 10.1002/cbdv.200690055.10.1002/cbdv.200690055Search in Google Scholar

Y. A. Al-Soud, H. Al-Sa'doni, H. A. S. Amajaour and N. A. Al-Masoudi, Nitroimidazoles Part 3. Synthesis and HIV activity of new N-alkyl-4-nitro-imidazoles bearing benzothiazole and benzoxazole backbone, Z. Naturforsch.62b (2007) 523-528.10.1515/znb-2007-0406Search in Google Scholar

Y. A. Al-Soud, N. A. Al-Masoudi, E. De Clercq and C. Pannecouque, Nitroimidazoles Part 4: Synthesis and HIV activity of new 5-alkylsulfanyl and 5-(4'-arylsulfonyl)piperazinyl-4-nitroimidazole derivatives, Heteroatom. Chem.18 (2007) 333-340; DOI: 10.1002/hc.20301.10.1002/hc.20301Search in Google Scholar

R. Pauwels, J. Balzarini, M. Baba, R. Snoeck, D. Schols, P. Herdewijn, J. Desmyter and E. De Clercq, Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds, J. Viro. Methods20 (1988) 309-321.10.1016/0166-0934(88)90134-6Search in Google Scholar

S. D. Young, S. F. Britcher, L. O. Tran, L. S. Payne, W. C. Lumma, T. A. Lyle, J. R. Huff, P. S. Anderson, D. B. Olsen, S. S. Carroll, D. J. Pettibone, J. A. Obrien, R. G. Ball, S. K. Balani, J. H. Lin, I. W. Chen, W. A. Schleif, V. V. Sardana, W. J. Long, V. W. Byrnes and E. A. Emini, L-743, 726 (DMP-266): A novel, highly potent non-nucleoside inhibitor of the human immunodeficiency-virus type-1 reverse transcriptase, Antimicrob. Agents Chemother.39 (1995) 2602-2605.Search in Google Scholar

J. S. Davis and A. K. Mohammed, Assessment of racemisation in N-alkylated amino-acid derivatives during peptide coupling in a model dipeptide system, J. Chem. Soc. Perkin Trans.1 (1981) 2982-2990; DOI: 10.1039/P19810002982.10.1039/p19810002982Search in Google Scholar

A. Asagarasu, T. Uchiyama and K. Achiwa, Synthesis of HIV-protease inhibitors having a peptide moiety which binds to gp 120, Chem. Pharm. Bull.46 (1989) 697-703.10.1248/cpb.46.697Search in Google Scholar

W. König and R. Geiger, Eine neue Methode zur Synthese von Peptiden: Aktivierung der Carboxylgruppe mit Dicyclohexylcarbodiimid unter Zusatz von 1-Hydroxy-Benzotriazolen, Chem. Ber.103 (1970) 788-798; DOI: 10.1002/cber.19701030319.10.1002/cber.19701030319Search in Google Scholar

R. M. Pennigton and R. R. Fischer, Dicyclohexylcarbodiimide modification of bovine heart mitochondrial transhydrogenase, J. Biol. Chem.256 (1981) 8963-8969.10.1016/S0021-9258(19)52493-0Search in Google Scholar

H. Jonckheere, J. Anné and E. De Clercq, The HIV-1 reverse transcription (RT) process as target for RT inhibitors, Med. Res. Rev.20 (2000) 129-154; DOI: 10.1002/(SICI)1098-1128.Search in Google Scholar

R. Esonouf, J. Ren, C. Ross, Y. Jones, D. Stammers and D. Stuart, Mechanism of inhibition of HIV-1 reverse transcriptase by non-nucleoside inhibitors, Nat. Struct. Mol. Biol.2 (1995) 303-308; DOI: 10.1038/nsb0495-303.10.1038/nsb0495-3037540935Search in Google Scholar